2025-10806Notice

SubQ Drug Squad Adds Gilead, Regeneron to Antitrust Safe Zone

Published Date: 6/13/2025

Notice

Summary

The Subcutaneous Drug Development & Delivery Consortium just added four new members, including big names like Gilead Sciences and Regeneron. This update keeps their special legal protections against antitrust lawsuits in place while they work together on drug research. If you’re involved or interested, watch for more membership updates coming soon—no big money changes yet, just teamwork growing stronger!

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
6/13/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Antitrust Division
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register